Genetic regulation of cardiogenesis and congenital heart disease

Deepak Srivastava1

  • 1Gladstone Institute of Cardiovascular Disease, Department of Pediatrics, University of California, San Francisco, California 94158, USA. dsrivastava@gladstone.ucsf.edu

Annual Review of Pathology
|November 28, 2007
PubMed

Insights

Genetic mutations causing developmental anomalies can lead to later-life cardiac dysfunction. Understanding early heart formation is key to preventing congenital heart defects and guiding stem cell therapies.

Area of Science:

  • Developmental biology
  • Cardiovascular research
  • Genetics

Background:

  • Congenital heart defects are the most common birth defects, affecting nearly 1% of newborns.
  • Survivors of congenital heart malformations may experience cardiac dysfunction later in life due to genetic causes.
  • Understanding the molecular basis of cardiogenesis is crucial for addressing these issues.

Purpose of the Study:

  • To review progress in understanding the molecular basis of cardiac formation.
  • To explore how disruptions in cardiogenesis lead to congenital heart defects.
  • To highlight the importance of early heart formation research for prevention and regenerative medicine.

Main Methods:

  • Literature review of studies on cardiogenesis and congenital heart defects.
  • Analysis of genetic mutations affecting heart development.
  • Synthesis of current knowledge on molecular pathways in cardiac formation.

Main Results:

  • Genetic mutations are increasingly recognized as causes of developmental anomalies leading to cardiac dysfunction.
  • Disruptions in the intricate steps of cardiogenesis are directly linked to congenital heart defects.
  • Insights into early heart formation provide a foundation for future research.

Conclusions:

  • Understanding the molecular mechanisms of heart development is essential for preventing congenital heart defects.
  • Knowledge gained from studying cardiogenesis informs strategies for managing long-term consequences in survivors.
  • This research is vital for developing approaches to guide stem cells into cardiac lineages for therapeutic purposes.

Related Concept Videos

Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...